文章摘要

文章信息/Info

Title:: Effect of standardized chronic disease management in patients with coronary heart disease

作者:: 李璐; 周鹏; 侯霁芯; (成都医学院第一附属医院心内科，四川成都 610500)

Author(s):: LI Lu; ZHOU Peng; HOU Qi-xin; (Department of Cardiology, First Affiliated Hospital, Chengdu Medical College, Chengdu 610500, Sichuan, China)

关键词:: 冠状动脉疾病; 疾病管理; 预后

Keywords:: coronary heart disease; chronic disease management; prognosis

分类号:: R541.4

DOI:: -

文献标识码:: A

摘要:: 目的:评估强化慢病管理门诊对冠心病患者的服药依从性，心血管事件再入院率，心功能评级的影响。方法:2012年1月~2013年12月在成都医学院第一附属医院心血管内科就诊的180例明确诊断冠心病的患者，分为强化管理组和一般管理组（对照组）。强化管理组每2周通过规范化慢病管理门诊方式随访，每3个月定期检测，一般管理组通过每月门诊或电话随访。观察两组患者服药依从性、心血管事件再入院率，心功能评级（NYHA评级）。结果:随访2年后发现，强化管理组阿斯匹林/ 氯吡格雷（74% vs. 54%，P<0.01）、他汀类药物（69% vs. 46%，P<0.01）、ACEI/ARB（76% vs. 46%，P<0.01）和β受体阻滞剂（63% vs. 42%，P<0.05）的服药率均优于一般管理组；因心血管事件再入院率也较低（26% vs. 42%，P<0.05）。结论:加强对冠心病患者的规范化管理，有助于提高患者服药依从性，减少患者心血管事件再入院率。

Abstract:: AIM:To evaluate the efficacy of standardized chronic disease management in outpatients with coronary heart disease in terms of drug compliance, cardiovascular events, readmission rate and rating of cardiac function. METHODS: One hundred and eighty patients with coronary heart disease were divided into standardized chronic disease management group and control group. The standardized chronic disease management group was followed up regularly and regular examination was conducted every 3 months, whereas the control group was followed up by telephone or clinic visit every month. Drug compliance, cardiovascular readmission rate, and heart function grading (NYHA grading) were observed. RESULTS: A 2-year follow-up showed that the percentage of taking aspirin and clopidogrel (74 vs. 54%, P<0.01), statins (69 vs. 46%, P<0.01), ACEI/ARB (76 vs. 46%, P<0.01) and beta blockers (42 vs. 63%, P<0.05) in standardized chronic disease management group were higher than those in the control group. Readmission rate of cardiovascular events in standardized chronic disease management group was also lower (26 vs. 42%, P<0.05) and the cardiac function class was better than those in control group. CONCLUSION: Standardized chronic disease management for patients with coronary heart disease improves drug compliance and reduces cardiovascular readmission rate.

参考文献/References

[1]吴锡桂.我国人群冠心病流行现况与趋势[J].中国慢性病预防与控制,2003,11(4):190-191.
[2]刘小清.冠心病流行病学研究进展及疾病负担[J].中华心血管病杂志,2008,36(6):573-576.
[3]Ma J,Lee KV,Berra K,et al.Implementation of case management to reduce cardiovascular disease risk in the Stanford and San Mateo Heart to Heart randomized controlled trial:study protocol and baseline characteristics[J].Implement Sci,2006,1:21.
[4]Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature[J].Circulation,1979,59(3):607-609.
[5]Qaseem A, Fihn SD, Dallas P, et al. Management of stable ischemic heart disease: summary of a clinical practice guideline from the American college of physicians/American college of cardiology foundation/American heart association/American association for thoracic surgery/preventive cardiovascular nurses association/society of thoracic surgeons[J].Ann Intern Med,2012,157(10):735-743.
[6]Mcalister FA,Lawson FM,Teo KK,et al.Randomised trials of secondary prevention programmes in coronary heart disease: systematic review[J].BMJ,2001,323(7319):957-962.
[7]吴锦晖,孙春丽,张绍敏,等.门诊规范化管理对老年冠心病患者预后的影响[J].中国循证医学杂志,2012,12(5):520-523.
[8]钟益刚,王宁夫,李虹,等.医院与社区联合进行院外冠心病患者的规范化管理[J].中华医学杂志,2010,90(38):2675-2678.

我们的网站为什么显示成这样？

强化慢病管理门诊对冠心病患者预后的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics